Phathom Pharmaceuticals, Inc. (PHAT) came out with a quarterly loss of $1.25 per share versus the Zacks Consensus Estimate of a loss of $1.20. This compares to loss of $0.84 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -4.17%. A quarter ago, it was expected that this company would post a loss of $1.43 per share when it actually produced a loss of $1.42, delivering a surprise of 0.70%. Over the last four quarters, the compa ...